Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease
Sebastian Heinzel(Christian-Albrechts-Universität zu Kiel), Filip Scheperjans(University of Helsinki), Gerhard W. Eschweiler(University Children's Hospital Tübingen), Petri Auvinen(University of Helsinki), Anna‐Katharina von Thaler(Christian-Albrechts-Universität zu Kiel), Sari Hantunen(University of Eastern Finland), Velma T. E. Aho(Norwegian University of Life Sciences), Ulrike Suenkel(Hertie Institute for Clinical Brain Research), Lars Paulín(University of Helsinki), Walter Maetzler(Centre Hospitalier Universitaire de Lille), Claudia Schulte(School of the Art Institute of Chicago), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Christian Deuschle(German Center for Neurodegenerative Diseases), Kathrin Brockmann(Oregon Health & Science University)
Cited by 70
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846